Trial Profile
Safety and efficacy of BAY 94-9027 in patients undergoing major surgery.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Apr 2014
Price :
$35
*
At a glance
- Drugs Damoctocog alfa pegol (Primary)
- Indications Perioperative haemorrhage
- Focus Therapeutic Use
- Sponsors Bayer HealthCare
- 03 Apr 2014 New trial record